MA26591A1 - Nouveaux derives de thiazole - Google Patents

Nouveaux derives de thiazole

Info

Publication number: MA26591A1
Authority: MA; Morocco
Prior art keywords: thiazole derivatives; new thiazole; new; derivatives; thiazole
Prior art date: 1998-01-02

Application number

MA25411A

Other languages

English (en)

Inventor

Alig Leo

Hilpert Kurt

Weller Thomas

Edenhofer Albrecht

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-02

Filing date

1998-12-30

Publication date

2004-12-20

1998-12-30 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26591A1 publication Critical patent/MA26591A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA25411A 1998-01-02 1998-12-30 Nouveaux derives de thiazole MA26591A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98100006		1998-01-02

Publications (1)

Publication Number	Publication Date
MA26591A1 true MA26591A1 (fr)	2004-12-20

Family

ID=8231229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25411A MA26591A1 (fr)	1998-01-02	1998-12-30	Nouveaux derives de thiazole

Country Status (29)

Country	Link
US (3)	US6100282A (fr)
JP (1)	JP3113237B2 (fr)
KR (1)	KR100312901B1 (fr)
CN (1)	CN1080720C (fr)
AR (1)	AR014949A1 (fr)
AT (1)	ATE233746T1 (fr)
AU (1)	AU720618B2 (fr)
BR (1)	BR9900006A (fr)
CA (1)	CA2257328C (fr)
CO (1)	CO4990934A1 (fr)
DE (1)	DE69811844T2 (fr)
DK (1)	DK0928790T3 (fr)
ES (1)	ES2193471T3 (fr)
HR (1)	HRP980645A2 (fr)
HU (1)	HUP9803040A3 (fr)
ID (1)	ID21936A (fr)
IL (1)	IL127785A (fr)
MA (1)	MA26591A1 (fr)
NO (1)	NO312067B1 (fr)
NZ (2)	NZ333590A (fr)
PE (1)	PE20000061A1 (fr)
PL (1)	PL330619A1 (fr)
PT (1)	PT928790E (fr)
RU (1)	RU2218337C2 (fr)
SG (1)	SG74686A1 (fr)
TR (1)	TR199802765A2 (fr)
UY (1)	UY25334A1 (fr)
YU (1)	YU61398A (fr)
ZA (1)	ZA9811925B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6919366B2 (en) *	1998-05-22	2005-07-19	Avanir Pharmaceuticals	Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) *	1998-05-22	2005-06-28	Avanir Pharmaceuticals	Benzimidazole compounds for regulating IgE
ES2221482T3 (es)	1998-10-22	2004-12-16	F. Hoffmann-La Roche Ag	Derivados de tiazol.
GB9826174D0 (en) *	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
AU5826100A (en)	1999-07-13	2001-01-30	F. Hoffmann-La Roche Ag	Benzazepinones and quinazolines
US6759425B2 (en) *	1999-10-21	2004-07-06	Avanir Pharmaceuticals	Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
CN1426303A (zh) *	2000-01-19	2003-06-25	奥尔顿有限公司	噻唑、咪唑和噁唑化合物以及与蛋白老化相关疾病的治疗
ES2291455T3 (es) *	2001-03-12	2008-03-01	Avanir Pharmaceuticals	Compuestos de bencimidazol para modular ige e inhibir la proliferacion celular.
AR038703A1 (es) *	2002-02-28	2005-01-26	Novartis Ag	Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
TWI276631B (en) *	2002-09-12	2007-03-21	Avanir Pharmaceuticals	Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en)	2002-09-12	2004-04-30	Avanir Pharmaceuticals	PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
CN100491361C (zh) *	2003-01-27	2009-05-27	安斯泰来制药有限公司	噻唑衍生物及其作为vap-1抑制剂的用途
WO2005013950A2 (fr) *	2003-08-08	2005-02-17	Avanir Pharmaceuticals	Inhibition pharmacologique selective du trafic proteique et methodes associees de traitement de maladies humaines
US7652146B2 (en) *	2004-02-06	2010-01-26	Bristol-Myers Squibb Company	Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
BRPI0516958A (pt) *	2004-09-20	2008-03-25	4Sc Ag	inibidores da nf-capab heterocìclicos
CA2593803A1 (fr) *	2005-01-26	2006-08-03	Irm Llc	Composes et compositions utilises en tant qu'inhibiteurs de proteines kinases
WO2008011191A1 (fr) *	2006-07-21	2008-01-24	Replidyne, Inc.	Urées hétérocycliques antibactériennes
WO2009015208A1 (fr)	2007-07-23	2009-01-29	Replidyne, Inc.	Composés urée hétérocycliques substitués par amide et sulfonamide antibactériens
US8293919B2 (en) *	2007-07-23	2012-10-23	Crestone, Inc.	Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds
AR075899A1 (es) *	2009-03-20	2011-05-04	Onyx Therapeutics Inc	Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
CN102936257B (zh) *	2012-08-30	2016-03-30	齐鲁工业大学	一类含银的噻唑西弗碱配合物的结构、制备和用途
EP3645531A1 (fr)	2017-06-29	2020-05-06	Bayer Aktiengesellschaft	Composés thiazole utiles en tant qu'inhibiteurs de prmt5
GB202012969D0 (en) *	2020-08-19	2020-09-30	Univ Of Oxford	Inhibitor compounds

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2009155B (en) *	1977-11-07	1982-07-21	Leo Pharm Prod Ltd	Chemical compounds
FR2581063B1 (fr)	1985-04-30	1987-07-17	Chauvin Blache Lab	Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS62123180A (ja) *	1985-11-21	1987-06-04	Otsuka Pharmaceut Factory Inc	ｐ−アミノフエノ−ル誘導体
US5000775A (en) *	1985-12-31	1991-03-19	Monsanto Company	2-amino-4,5-disubstituted-oxazole/thiazole compounds as herbicide antidotes
JPS6348873A (ja) *	1986-08-19	1988-03-01	Toshiba Corp	ガスレ−ザ発振装置
CA2037153A1 (fr) *	1990-03-09	1991-09-10	Leo Alig	Derives de l'acide acetique
US5273982A (en) *	1990-03-09	1993-12-28	Hoffmann-La Roche Inc.	Acetic acid derivatives
FI922867A7 (fi) *	1991-06-21	1992-12-22	Tanabe Seiyaku Co	Dikarbonsyraderivat och foerfarande foer framstaellning av dem
US5294713A (en) *	1991-08-23	1994-03-15	Takeda Chemical Industries, Ltd.	2-piperazinone compounds and their use
GB9125970D0 (en) *	1991-12-06	1992-02-05	Fujisawa Pharmaceutical Co	New compounds
US5514643A (en) *	1993-08-16	1996-05-07	Lucky Ltd.	2-aminothiazolecarboxamide derivatives, processes for preparing the same and use thereof for controlling phytopathogenic organisms
JPH0867676A (ja) *	1994-03-30	1996-03-12	Eisai Kagaku Kk	保護アミノチアゾリル酢酸誘導体
US6306840B1 (en) *	1995-01-23	2001-10-23	Biogen, Inc.	Cell adhesion inhibitors
JPH08337579A (ja) *	1995-06-14	1996-12-24	Fujisawa Pharmaceut Co Ltd	グアニジノチアゾ−ルおよびその抗潰瘍剤、ｈ２−受容体拮抗剤および抗菌剤としての用途
NZ299242A (en) *	1995-09-11	1997-12-19	Nihon Nohyaku Co Ltd	N-phenyl-n'-(phenyl substituted imidazol-5-yl, -oxazol-4-yl, and -thiazol-4-yl)urea derivatives
JPH09295974A (ja) *	1995-09-11	1997-11-18	Nippon Nohyaku Co Ltd	アゾール誘導体、その用途及びその製造方法並びにその使用方法
KR19990076964A (ko) *	1995-12-29	1999-10-25	데이비드 이. 프랭크하우저	항헤르페스 바이러스 특성을 갖는 페닐 티아졸 유도체
DE69815906T2 (de) *	1997-02-13	2004-02-05	Tokuyama Corp., Tokuya	Verfahren zur Herstellung von Chloroacetylaminothiazoleaceticsäure Derivate
MA26487A1 (fr) *	1997-04-29	2004-12-20	Smithkline Beecham Corp	Heterocyclecetohydrazides inhibiteurs de proteases, procede pour leur preparation et compositions pharmaceutiques les contenant .
JP6348873B2 (ja)	2015-04-24	2018-06-27	株式会社ソフイア	遊技機

1998
- 1998-12-22 US US09/218,567 patent/US6100282A/en not_active Expired - Fee Related
- 1998-12-24 AT AT98124670T patent/ATE233746T1/de not_active IP Right Cessation
- 1998-12-24 DE DE69811844T patent/DE69811844T2/de not_active Expired - Fee Related
- 1998-12-24 NZ NZ333590A patent/NZ333590A/xx unknown
- 1998-12-24 DK DK98124670T patent/DK0928790T3/da active
- 1998-12-24 ES ES98124670T patent/ES2193471T3/es not_active Expired - Lifetime
- 1998-12-24 NZ NZ333591A patent/NZ333591A/xx unknown
- 1998-12-24 PT PT98124670T patent/PT928790E/pt unknown
- 1998-12-28 NO NO19986159A patent/NO312067B1/no unknown
- 1998-12-29 IL IL12778598A patent/IL127785A/en not_active IP Right Cessation
- 1998-12-29 ZA ZA9811925A patent/ZA9811925B/xx unknown
- 1998-12-29 PE PE1998001293A patent/PE20000061A1/es not_active Application Discontinuation
- 1998-12-29 AR ARP980106723A patent/AR014949A1/es not_active Application Discontinuation
- 1998-12-29 HR HR98100006.0A patent/HRP980645A2/hr not_active Application Discontinuation
- 1998-12-30 HU HU9803040A patent/HUP9803040A3/hu unknown
- 1998-12-30 SG SG1998005978A patent/SG74686A1/en unknown
- 1998-12-30 CA CA002257328A patent/CA2257328C/fr not_active Expired - Fee Related
- 1998-12-30 PL PL98330619A patent/PL330619A1/xx not_active Application Discontinuation
- 1998-12-30 AU AU96144/98A patent/AU720618B2/en not_active Ceased
- 1998-12-30 MA MA25411A patent/MA26591A1/fr unknown
- 1998-12-30 YU YU61398A patent/YU61398A/sh unknown
- 1998-12-30 CO CO98077476A patent/CO4990934A1/es unknown
- 1998-12-30 TR TR1998/02765A patent/TR199802765A2/xx unknown
- 1998-12-31 KR KR1019980063364A patent/KR100312901B1/ko not_active Expired - Fee Related
- 1998-12-31 UY UY25334A patent/UY25334A1/es not_active IP Right Cessation
- 1998-12-31 CN CN98125982A patent/CN1080720C/zh not_active Expired - Fee Related
1999
- 1999-01-04 BR BR9900006-7A patent/BR9900006A/pt not_active Application Discontinuation
- 1999-01-04 JP JP11000010A patent/JP3113237B2/ja not_active Expired - Fee Related
- 1999-01-04 ID IDP990001D patent/ID21936A/id unknown
- 1999-01-05 RU RU99100277/04A patent/RU2218337C2/ru not_active IP Right Cessation
2000
- 2000-03-15 US US09/526,033 patent/US6320054B1/en not_active Expired - Fee Related
2001
- 2001-06-11 US US09/878,704 patent/US6344562B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR19990066925A (ko)	1999-08-16
HRP980645A2 (en)	1999-10-31
NZ333590A (en)	2000-05-26
PL330619A1 (en)	1999-07-05
BR9900006A (pt)	2000-04-11
TR199802765A3 (tr)	1999-07-21
TR199802765A2 (xx)	1999-07-21
NO312067B1 (no)	2002-03-11
CA2257328C (fr)	2006-05-09
ZA9811925B (en)	2000-06-29
IL127785A0 (en)	1999-10-28
HU9803040D0 (en)	1999-02-01
IL127785A (en)	2004-09-27
CN1224718A (zh)	1999-08-04
AU720618B2 (en)	2000-06-08
CN1080720C (zh)	2002-03-13
US6100282A (en)	2000-08-08
US6320054B1 (en)	2001-11-20
US20020010316A1 (en)	2002-01-24
DE69811844D1 (de)	2003-04-10
NO986159D0 (no)	1998-12-28
UY25334A1 (es)	2001-01-31
ES2193471T3 (es)	2003-11-01
DK0928790T3 (da)	2003-06-30
AU9614498A (en)	1999-07-22
US6344562B1 (en)	2002-02-05
PE20000061A1 (es)	2000-02-09
ATE233746T1 (de)	2003-03-15
SG74686A1 (en)	2000-08-22
PT928790E (pt)	2003-07-31
JP3113237B2 (ja)	2000-11-27
NZ333591A (en)	2000-05-26
RU2218337C2 (ru)	2003-12-10
HK1020953A1 (en)	2000-05-26
DE69811844T2 (de)	2003-12-04
KR100312901B1 (ko)	2002-01-15
JP2000053664A (ja)	2000-02-22
HUP9803040A2 (hu)	2000-04-28
NO986159L (no)	1999-07-05
YU61398A (sh)	2001-12-26
CA2257328A1 (fr)	1999-07-02
ID21936A (id)	1999-08-12
AR014949A1 (es)	2001-04-11
HUP9803040A3 (en)	2001-04-28
CO4990934A1 (es)	2000-12-26

Publication	Publication Date	Title
MA26591A1 (fr)	2004-12-20	Nouveaux derives de thiazole
NO20010193L (no)	2001-01-12	Tiobenzimidazol-derivater
MA26766A1 (fr)	2004-12-20	Derives de phenylglycine
ATE236136T1 (de)	2003-04-15	Benzosulfonderivate
FR12C0007I2 (fr)	2012-10-26	Nouveaux derives de phenyle-propargylether
NO20010514D0 (no)	2001-01-30	Aminometylkarboksylsyre-derivater
ATE259810T1 (de)	2004-03-15	Phenyl-xanthinderivate
DK1115716T3 (da)	2003-02-24	2-phenylpyran-4-on-derivater
PT1056716E (pt)	2003-04-30	Derivados de ciclo-hexanodiolo
DK1134219T3 (da)	2005-10-17	Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de)	2003-03-15	Chromanderivate
MA26756A1 (fr)	2004-12-20	Derives de thiazole
DK1060183T3 (da)	2003-08-11	5-deoxycytidinderivater
DE69805392D1 (de)	2002-06-20	Thiazol-Derivate
DE59907635D1 (de)	2003-12-11	Pyrazolyldioxothiochromanoyl-derivate
MA24068A1 (fr)	1997-10-01	Nouveaux derives de 19-nor- pregnene